MOHAMED HEGAZY to Treatment Outcome
This is a "connection" page, showing publications MOHAMED HEGAZY has written about Treatment Outcome.
Connection Strength
0.050
-
Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry. Semin Arthritis Rheum. 2026 Oct; 80:153030.
Score: 0.020
-
Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry. Clin Exp Ophthalmol. 2025 Aug; 53(6):619-626.
Score: 0.018
-
Marine Natural Products: A Source of Novel Anticancer Drugs. Mar Drugs. 2019 Aug 23; 17(9).
Score: 0.012